Lundbeck has made over 1 trades of the Imara Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently Lundbeck bought 85,923,561 units of IMRA stock worth $543,036,906 on 22 October 2019.
The largest trade Lundbeck's ever made was buying 85,923,561 units of Imara Inc stock on 22 October 2019 worth over $543,036,906. On average, Lundbeck trades about 42,961,781 units every 0 days since 2019.
You can see the complete history of Lundbeck H stock trades at the bottom of the page.
Lundbeck's mailing address filed with the SEC is OTTILIAVEJ 9, , VALBY, G7, DK-2500.
Over the last 5 years, insiders at Imara Inc have traded over $7,889,059 worth of Imara Inc stock and bought 11,496,717 units worth $107,874,489 . The most active insiders traders include David M Mott, Lundbeck A S H, and Capital Management, L.P.Ra .... On average, Imara Inc executives and independent directors trade stock every 23 days with the average trade being worth of $1,965,179. The most recent stock trade was executed by Michael Gray on 22 February 2023, trading 9,856 units of IMRA stock currently worth $46,028.
Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Imara is currently advancing IMR-687, a highly selective, potent small molecule inhibitor of PDE9 that is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease and beta-thalassemia.
Imara Inc executives and other stock owners filed with the SEC include: